This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. A warning letter posted Tuesday by the Food and Drug ...
LONDON--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM ...
EDINBURGH, Scotland & SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of ...
DexCom Inc (NASDAQ:DXCM) shares are down more than 8% Monday afternoon after Abbott Laboratories (NYSE:ABT) announced that the U.S. Food and Drug Administration (FDA) has cleared its FreeStyle Libre 2 ...
Dexcom raised its sales expectations for 2025 amid expanding access to its glucose sensors for people with Type 2 diabetes. The company raised its revenue forecast to a range of $4.6 billion to about ...
Dexcom ONE+ is available today in Spain, Belgium, and Poland with the Netherlands launching next week, and additional countries to be announced in the coming months. New system continues to ensure ...
Dexcom ONE+ is available today in Spain, Belgium, and Poland with the Netherlands launching next week, and additional countries to be announced in the coming months. New system continues to ensure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback